e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Monitoring airway diseases with lung function tests
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled particles from small airways in COPD patients – A pilot study
M. Lärstad, S. Larsson, B. Bake, A. C. Olin (Gothenburg, Sweden)
Source:
International Congress 2014 – Monitoring airway diseases with lung function tests
Session:
Monitoring airway diseases with lung function tests
Session type:
Thematic Poster Session
Number:
3977
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Lärstad, S. Larsson, B. Bake, A. C. Olin (Gothenburg, Sweden). Exhaled particles from small airways in COPD patients – A pilot study. Eur Respir J 2014; 44: Suppl. 58, 3977
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Risk factors associated with the development of interstitial lung abnormalities
Related content which might interest you:
Small airways obstruction and exhaled particles in asthma
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
Exhaled breath condensate hydrogen peroxide in obstructive airways disease
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Double-tracer gas washout in stable asthma and COPD
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Exhaled particles as markers of small airways inflammation in asthmatic subjects
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
The effects of oral care on FeNO measurement in asthmatic patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Monitoring exhaled carbon monoxide in COPD exacerbations
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Exhaled endogenous particles in a general population sample enriched with asthma subjects
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
The amount of endogenous particles in exhaled air is correlated to peripheral airway obstruction
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Determinants of exhaled particles of a standardized breathing maneuver
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Air trapping in relation to airways inflammation and bronchial responsiveness in patients with respiratory symptoms suggestive of asthma
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Exhaled breath condensate pH in exercise-induced bronchoconstriction
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Exhaled NO but not eosinophilic inflammation is reduced by inhaled corticosteroid treatment in COPD
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Exhaled breath temperature in asthmatic and healthy children: A case-control study
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Induced sputum and bronchial hyperresponsiveness in COPD patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Bronchodilation test estimation using spirometry and electrical impedance analysis in bronchial asthma and COPD patients
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015
Relation of exhaled breath temperature and systemic markers of inflammation and remodelling in stable bronchial asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Exhaled breath analysis for identifying eosinophilic and neutrophilic inflammation in a mixed population of patients with asthma or COPD
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Body-plethysmographic measurements of bronchodilator response in stable COPD
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept